EMA

European Medicines Agency

The SLCMSR has been shortlisted as a potential contractor of the EMA for Lots 1,2,3 and 4.
Valid until 02. April 2015

1-Comparative reviews of drug utilisation patterns
2-Observational studies (electronic healthcare and other databases)
3-Observational safety or benefit:risk studies (primary data collection)
4-Systematic reviews or meta-analysis

AttachmentSize
Briefing Book actibelt_EMA qualification_final.pdf679.3 KB